WORK Medical Technology Group (NASDAQ:WOK – Get Free Report) and Ekso Bionics (NASDAQ:EKSO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings.
Valuation and Earnings
This table compares WORK Medical Technology Group and Ekso Bionics”s gross revenue, earnings per share (EPS) and valuation.
Get WORK Medical Technology Group alerts: WORK Medical Technology Group has higher earnings, but lower revenue than Ekso Bionics.
Analyst Ratings
This is a summary of current recommendations and price targets for WORK Medical Technology Group and Ekso Bionics, as provided by MarketBeat.
Ekso Bionics has a consensus target price of $562.50, suggesting a potential upside of 11,038.61%. Given Ekso Bionics’ stronger consensus rating and higher probable upside, analysts clearly believe Ekso Bionics is more favorable than WORK Medical Technology Group.
Insider and Institutional Ownership
6.4% of Ekso Bionics shares are owned by institutional investors. 6.0% of Ekso Bionics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares WORK Medical Technology Group and Ekso Bionics’ net margins, return on equity and return on assets.
Summary
Ekso Bionics beats WORK Medical Technology Group on 7 of the 11 factors compared between the two stocks.
About WORK Medical Technology Group
(Get Free Report)
WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.
About Ekso Bionics
(Get Free Report)
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker’s arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Critical Analysis: Ekso Bionics (NASDAQ:EKSO) & WORK Medical Technology Group (NASDAQ:WOK)
